Carmichael Hill & Associates’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7
| Closed | -$49 | – | 709 |
|
|
2023
Q1 | $49 | Hold |
7
| – | – | ﹤0.01% | 677 |
|
|
2022
Q4 | $72 | Hold |
7
| – | – | ﹤0.01% | 659 |
|
|
2022
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 756 |
|
|
2022
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 759 |
|
|
2022
Q1 | $1K | Hold |
7
| – | – | ﹤0.01% | 658 |
|
|
2021
Q4 | $1K | Sell |
7
-6
| -46% | -$857 | ﹤0.01% | 659 |
|
|
2021
Q3 | $3K | Hold |
13
| – | – | ﹤0.01% | 614 |
|
|
2021
Q2 | $3K | Hold |
13
| – | – | ﹤0.01% | 598 |
|
|
2021
Q1 | $2K | Hold |
13
| – | – | ﹤0.01% | 612 |
|
|
2020
Q4 | $1K | Sell |
13
-7
| -35% | -$538 | ﹤0.01% | 618 |
|
|
2020
Q3 | $2K | Sell |
20
-30
| -60% | -$3K | ﹤0.01% | 574 |
|
|
2020
Q2 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 494 |
|